Base to Base biotech podcast 53: Diagnosing autism and improving transplant outcomes
IND approval for bispecific ADC
World’s largest clinically linked spatial biology atlas launched
Changing the search for rare disease diagnoses with AI breakthrough
Crossbow Therapeutics raises $77m to treat cancer
Base to Base biotech podcast 52: Ketamine for depression, and a new company in the kidney disease space
Excalipoint Therapeutics launches with $68.7m to develop T-Cell engager therapies
FDA clearance for refractory gout treatment
Earendil Labs raises $787m to scale AI-driven biologics discovery and development
Researchers design drug capable of reversing cognitive decline in Alzheimer’s disease
Shingles vaccine cuts risk of serious cardiac events
Initial data suggest favourable safety profile for Alzheimer’s drug